TRENTON, N.J. - Two days into trial, a New Jersey federal judge presiding over the second Fosamax femur fracture trial denied Merck Sharp and Dohme Corp.'s motion to exclude causation testimony by four plaintiff expert witnesses (In Re: Fosamax $(Alendronate Sodium$) Products Liability Litigation, MDL Docket No. 08-md-00008, Bernadette Glynn, et al. v. Merck Sharpe & Dohme Corp., No. 11-5304, D. N.J.)....(read more)![]()
↧